Sanofi-Aventis to boost Lantus production in China

04/21/2009 | Reuters

Sanofi-Aventis plans to invest $90 million to increase production of the insulin Lantus in China by 2012. The move comes after a string of acquisitions Sanofi made in Mexico, Brazil and the U.S.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Chief Executive Officer
UCare Minnesota
Minneapolis, MN